NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding

被引:58
|
作者
Tugarinov, V
Zvi, A
Levy, R
Hayek, Y
Matsushita, S
Anglister, J [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel
[2] Kumamoto Univ, Sch Med, Ctr AIDS Res, Kumamoto 8608556, Japan
来源
STRUCTURE WITH FOLDING & DESIGN | 2000年 / 8卷 / 04期
关键词
anti-gp120; antibody; co-receptor; HIV-1; NMR; V3; loop;
D O I
10.1016/S0969-2126(00)00119-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The protein 0.5 beta is a potent strain-specific human immunodeficiency virus type 1 (HIV-1) neutralizing antibody raised against the entire envelope glycoprotein (gp120) of the HIV-1(IIIB) strain. The epitope recognized by 0.5 beta is located within the third hypervariable region (V3) of gp120. Recently, several HIV-1 V3 residues involved in co-receptor utilization and selection were identified. Results: Virtually complete sidechain assignment of the variable fragment (Fv) of 0.5 beta in complex with the V3(IIIB) peptide P1053 (RKSIRIQRGPGRAFVTIG, in single-letter amino acid code) was accomplished and the combining site structure of 0.5 beta Fv complexed with P1053 was solved using multidimensional nuclear magnetic resonance (NMR). Five of the six complementarity determining regions (CDRs) of the antibody adopt standard canonical conformations, whereas CDR3 of the heavy chain assumes an unexpected fold. The epitope recognized by 0.5 beta encompasses 14 of the 18 P1053 residues. The bound peptide assumes a beta-hairpin conformation with a QRGPGR loop located at the very center of the binding pocket. The Fv and peptide surface areas buried upon binding are 601 Angstrom and 743 Angstrom(2), respectively, in the 0.5 beta Fv-P1053 mean structure. The surface of P1053 interacting with the antibody is more extensive and the V3 peptide orientation in the binding site is significantly different compared with those derived from the crystal structures of a V3 peptide of the HIV-1 MN strain (V3(MN)) complexed to three different anti-peptide antibodies. Conclusions: The surface of P1053 that is in contact with the anti-protein antibody 0.5 beta is likely to correspond to a solvent-exposed region in the native gp120 molecule. Some residues of this region of gp120 are involved in co-receptor binding, and in discrimination between different chemokine receptors utilized by the protein. Several highly variable residues in the V3 loop limit the specificity of the 0.5 beta antibody, helping the virus to escape from the immune system. The highly conserved GPG sequence might have a role in maintaining the beta-hairpin conformation of the V3 loop despite insertions, deletions and mutations in the flanking regions.
引用
收藏
页码:385 / 395
页数:11
相关论文
共 21 条
  • [1] NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity
    Sharon, M
    Rosen, O
    Anglister, J
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (05) : 601 - 612
  • [2] Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120
    Chandramouli, Balasubramanian
    Chillemi, Giovanni
    Giombini, Emanuela
    Capobianchi, Maria R.
    Rozera, Gabriella
    Desideri, Alessandro
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2013, 31 (04) : 403 - 413
  • [3] A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints
    Zvi, A
    Tugarinov, V
    Faiman, GA
    Horovitz, A
    Anglister, J
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (03): : 767 - 779
  • [4] Importance of V3 Loop Flexibility and Net Charge in the Context of Co-Receptor Recognition. A Molecular Dynamics Study on HIV gp120
    Chandramouli, Balasubramanian
    Chillemi, Giovanni
    Abbate, Isabella
    Capobianchi, Maria R.
    Rozera, Gabriella
    Desideri, Alessandro
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2012, 29 (05) : 879 - 891
  • [5] Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies
    Sharon, M
    Görlach, M
    Levy, R
    Hayek, Y
    Anglister, J
    PROTEIN EXPRESSION AND PURIFICATION, 2002, 24 (03) : 374 - 383
  • [6] Substitution of gp120 C4 region compensates for V3 loss-of-fitness mutations in HIV-1 CRF01_AE co-receptor switching
    Yu, Yueyang
    Feng, Yi
    Zhou, Zehua
    Li, Kang
    Hu, Xiaoyan
    Liao, Lingjie
    Xing, Hui
    Shao, Yimig
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [7] Discovery of novel anti-HIV-1 agents based on a broadly neutralizing antibody against the envelope gp120 V3 loop: a computational study
    Andrianov, Alexander M.
    Kashyn, Ivan A.
    Tuzikov, Alexander V.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2014, 32 (12) : 1993 - 2004
  • [8] Structure of antibody f425-b4e8 in complex with a v3 peptide reveals a new binding mode for HIV-1 neutralization
    Bell, Christian H.
    Pantophlet, Ralph
    Schiefner, Andre
    Cavacini, Lisa A.
    Stanfield, Robyn L.
    Burton, Dennis R.
    Wilson, Ian A.
    JOURNAL OF MOLECULAR BIOLOGY, 2008, 375 (04) : 969 - 978
  • [9] Probing hydrogen bonds in the antibody-bound HIV-1 gp120 V3 loop by solid state NMR REDOR measurements
    Balbach, JJ
    Yang, J
    Weliky, DP
    Steinbach, PJ
    Tugarinov, V
    Anglister, J
    Tycko, R
    JOURNAL OF BIOMOLECULAR NMR, 2000, 16 (04) : 313 - 327
  • [10] Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120V3 signatures in the regulation of co-receptor usage
    Dimonte, Salvatore
    Babakir-Mina, Muhammed
    Mercurio, Fabio
    Di Pinto, Domenico
    Ceccherini-Silberstein, Francesca
    Svicher, Valentina
    Perno, Carlo-Federico
    VIRUS RESEARCH, 2012, 168 (1-2) : 73 - 83